Rikkunshito increases peripheral incretin-hormone levels in humans and rats

Figure 2 Effects of rikkunshito on plasma incretin levels. A and B: Plasma levels of (A): Gastric inhibitory peptide; and (B): Glucagon-like polypeptide-1 were measured by ELISA. Rikkunshito (TJ-43); TJ-43(−), patients without TJ-43 treatment; and TJ43(+), patients with TJ-43 treatment. ^aP < 0.05 compared with the TJ-43(−) group by ANOVA with Bonferroni’s post-hoc test. TJ-43: Rikkunshito; GIP: Gastric inhibitory peptide; GLP-1: Glucagon-like polypeptide-1; POD: Postoperative day.